Iqvia Holdings (IQV) EBITDA Margin (2012 - 2026)
Iqvia Holdings' (IQV) quarterly EBITDA Margin came in at 11.58% in Q2 2026, down 101.0% year-over-year from 1158.42% in Q2 2025, and down 6.45% quarter-over-quarter from 12.38% in Q1 2026.
Analysis
Iqvia Holdings (IQV) EBITDA Margin (2012 - 2026) Analysis & Trends
Iqvia Holdings has disclosed EBITDA Margin across 15 years of filings, most recently posting 11.58% for Q2 2026.
- In Q2 2026, EBITDA Margin fell 101.0% year-over-year to 11.58%; the TTM figure through Jun 2026 stood at 12.95% (down 92.0% YoY), while the FY2025 annual figure was 14.36%, down 90.0% from the prior year.
- EBITDA Margin came in at 11.58% for Q2 2026 at Iqvia Holdings, down from 12.38% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 15.82% in Q4 2024 to a low of 10.14% in Q4 2022.
- Average EBITDA Margin over 5 years is 13.18%, with a median of 13.1% recorded in 2022.
- The largest YoY upside for EBITDA Margin was 447 bps in 2022 against a maximum downside of 260 bps in 2022.
- Over 5 years, EBITDA Margin stood at 10.14% in 2022, then rose by 28 bps to 12.95% in 2023, then advanced by 22 bps to 15.82% in 2024, then fell by 9 bps to 14.37% in 2025, then fell by 19 bps to 11.58% in 2026.
- Per Business Quant data, the three most recent EBITDA Margin figures were 11.58% in Q2 2026, 12.38% in Q1 2026, and 14.37% in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 11.58% |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 21.68% |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 15.86% |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 11.94% |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 2.18% |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | -290.47% |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | -2.69% |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | -218,381.69% |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | -15,327.78% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.58% |
| Mar 31, 2026 | 12.38% |
| Dec 31, 2025 | 14.37% |
| Sep 30, 2025 | 13.49% |
| Jun 30, 2025 | 12.60% |
| Mar 31, 2025 | 12.95% |
| Dec 31, 2024 | 15.82% |
| Sep 30, 2024 | 14.12% |
| Jun 30, 2024 | 13.63% |
| Mar 31, 2024 | 13.54% |
| Dec 31, 2023 | 12.95% |
| Sep 30, 2023 | 12.87% |
| Jun 30, 2023 | 14.06% |
| Mar 31, 2023 | 12.90% |
| Dec 31, 2022 | 10.14% |
| Sep 30, 2022 | 13.25% |
| Jun 30, 2022 | 12.79% |
| Mar 31, 2022 | 13.87% |
| Dec 31, 2021 | 12.73% |
| Sep 30, 2021 | 8.91% |